Sun Pharma Introduces Dry Eye Treatment Medication

Sun Pharmaceutical Industries announced on Tuesday that it has launched a medication in the country to treat dry eye disease. The Mumbai-based pharmaceutical company announced the launch of Cequa, a novel ophthalmology treatment for patients suffering from dry eye disease (DED) with inflammation, a common condition. Sun Pharma claims that Cequa is the first dry eye treatment available in India that uses nanomicellar technology.

"Because current treatment options for dry eye disease are limited, there is a significant unmet need in this area. Sun Pharma India Business CEO Kirti Ganorkar stated, "We are excited to introduce Cequa as a new treatment option." In India, the prevalence of DED is higher than the global prevalence. The disease causes a scratchy sensation in the eye or the sensation that something is in the eye. Other symptoms include stinging or burning, excessive watering after stressful periods, discharge, pain, and redness in the eye. On the BSE, Sun Pharma shares were trading 0.19 percent lower at Rs 977.35 per share.